← FDA DRUG APPROVALS

FDA NDA · NDA013077

XYLOCAINE

Sponsor: ASTRAZENECA

APPLICATION
NDA013077
TYPE
NDA
ORIGINAL APPROVAL
1964-03-06
LATEST ACTION
1964-03-06
ROUTE
RECTAL
DOSAGE FORM
SUPPOSITORY
MARKETING STATUS
Discontinued

Products

XYLOCAINEDiscontinued
LIDOCAINE 100MG · SUPPOSITORY · RECTAL

Approval history

1964-03-06Type 4 - New Combination · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →